Assessment of the Effectiveness of Obesity Treatment Methods – Historical Review

Beginning in the 1970s, nutritional regimens characterized by a marked reduction in carbohydrate intake gained substantial traction among both nutrition professionals and individuals seeking weight management solutions. The defining feature of these low-carbohydrate dietary approaches is the restriction of carbohydrate consumption to no more than 25 percent of total daily caloric requirements. Current dietary guidelines classify this threshold as the absolute minimum necessary to sustain the metabolic demands of glucose-dependent tissues and organs, which rely on a steady supply of glucose as their primary energy substrate. Among the most widely recognized examples of this dietary category are the nutritional protocol developed by Dr. Robert Atkins—commonly referred to as the Atkins Diet—as well as the dietary model proposed by Dr. Jan Kwaśniewski, often described as the Optimal Diet. In subsequent decades, additional variants emerged and gained prominence, including the high-protein Dukan Diet and the so-called Paleolithic Diet, which draws inspiration from the presumed eating patterns of our prehistoric ancestors. Extensive clinical research confirms that adherence to low-carbohydrate diets can yield measurable benefits in terms of body weight reduction. However, comparative meta-analyses evaluating diverse dietary interventions—such as low-fat diets, low-protein regimens, and conventional hypocaloric diets—have failed to demonstrate statistically significant differences in long-term efficacy across these approaches. It is critical to emphasize that improperly balanced or physiologically inappropriate dietary patterns may disrupt systemic homeostasis, thereby compromising overall health status and potentially undermining the ultimate objective of achieving and maintaining a physiologically appropriate body weight.

At present, the cornerstone of obesity treatment remains a personalized dietary approach founded on a meticulously calculated caloric deficit designed to facilitate gradual yet sustainable weight loss. An optimal reduction diet must ensure comprehensive provision of all macronutrients—including complex carbohydrates, high-quality proteins, and unsaturated fatty acids—as well as micronutrients such as vitamins and minerals in quantities tailored to the patient’s metabolic requirements. Particular emphasis is placed on the rate of weight reduction: a systematic decrease of 0.5 to 1 kilogram per week (equivalent to 2 to 4 kilograms monthly) is recommended, as this pace minimizes the risk of weight cycling (yo-yo effect) and promotes long-term maintenance of achieved outcomes. Additionally, the diet should be rich in dietary fiber (both soluble and insoluble) while restricting the intake of rapidly digestible carbohydrates—i.e., foods with a high glycemic index—which supports glucose homeostasis and enhances satiety.

Contemporary therapeutic guidelines unequivocally emphasize that regular physical activity—alongside dietary modifications—constitutes an indispensable pillar of comprehensive obesity management. The recommended modalities prioritize low-impact exercises, including brisk walking, water-based activities (such as swimming or aquatic aerobics), isometric routines, and movement-centered relaxation techniques like yoga sequences. The most effective strategy involves a phased escalation of exercise intensity, initially targeting a daily energy expenditure of 100–200 kilocalories. Early sessions should be performed at 50–70% of an individual’s maximal oxygen uptake (VO₂max), with a frequency of three sessions per week. Systematic reviews, including research by Brończyk-Puzon et al., demonstrate that patients combining caloric restriction with structured physical activity achieve significantly superior weight loss outcomes compared to cohorts relying solely on dietary interventions without an exercise component.

When modifications to dietary habits and increased physical activity prove insufficient to achieve therapeutic goals—particularly in individuals with comorbid conditions such as hypertension, impaired glucose metabolism, or dyslipidemia—pharmacological intervention may be warranted. The origins of anti-obesity pharmacotherapy trace back to the 1950s in the United States, where deoxyephedrine became the first agent approved for this purpose. Within the European Union, sibutramine was introduced in 1999 but was withdrawn from the market in 2010 after evidence emerged linking its use to an elevated risk of cardiovascular events, including myocardial infarction and stroke, as well as adverse effects such as elevated blood pressure and vertigo. Another compound, rimonabant, was discontinued just two years post-launch due to severe neuropsychiatric adverse reactions, primarily depressive disorders and anxiety. Currently, two pharmacological agents remain available: Orlistat, which functions by inhibiting the absorption of approximately 30% of ingested dietary fats but is associated with side effects such as steatorrhea and potential deficiencies in fat-soluble vitamins, and Mysimba, which modulates neurotransmitter activity in appetite-regulating centers of the brain, thereby reducing food intake. Research conducted by Olszanecka-Glinianowicz et al. demonstrates that, beyond promoting weight loss, Mysimba also exerts beneficial effects on insulin sensitivity, reduces triglyceride concentrations, and increases high-density lipoprotein (HDL) levels—commonly referred to as "good" cholesterol.

Beginning in the 1950s and 1960s, clinical practice saw the introduction of surgical procedures based on diverse variations of intestinal anastomoses, designed primarily to impose restrictions on digestive and absorptive processes. While these methods achieved the intended outcome of weight reduction, they were concurrently associated with a spectrum of adverse effects and complications. A subsequent milestone occurred in the 1960s with the advent of pioneering restrictive surgeries involving the segmentation of the stomach. The 1980s then introduced a minimally invasive technique centered on the application of an adjustable gastric band. However, the true revolution in bariatric surgery unfolded in the 1990s with the widespread adoption of laparoscopic techniques. Research conducted by Kowalewski P. et al. demonstrated that sleeve gastrectomy emerged as the most effective long-term solution, enabling 50% of patients to achieve and sustain satisfactory weight loss. In contrast, only 11% of patients with adjustable gastric bands attained a durable bariatric outcome. Presently, Poland is experiencing a steady increase in the number of bariatric procedures performed annually, with laparoscopic sleeve gastrectomy and laparoscopic gastric bypass representing the most frequently employed techniques. Globally, the second most common method remains gastric banding with an adjustable silicone band positioned around the upper portion of the stomach. The advantages of this approach include its relative technical simplicity—eliminating the need for anastomoses—and the preservation of the natural anatomical relationships within the gastrointestinal tract. Nevertheless, this technique carries risks such as gastroesophageal reflux, vomiting episodes, band slippage, dilation of the small gastric pouch, or band erosion into the stomach. It is critical to acknowledge that all surgical interventions entail inherent risks, including potential injury to adjacent organs, hemorrhage, infections, or the formation of abdominal adhesions. Eligibility for bariatric surgery extends to adult patients with a body mass index (BMI) exceeding 40 kg/m² or a BMI above 35 kg/m² accompanied by obesity-related comorbidities, such as hypertension, type 2 diabetes mellitus, metabolic syndrome, or restrictive respiratory disorders.

Within the framework of a comprehensive approach to obesity treatment, the psychologist assumes a pivotal role by collaborating with a multidisciplinary team—comprising the attending physician, a clinically experienced dietitian, and a physiotherapist—to formulate individualized therapeutic strategies. Beyond systematically supporting the patient throughout each phase of the treatment journey, the psychologist’s responsibilities include fostering intrinsic motivation to initiate therapy, persist with the prescribed interventions, and consolidate the health improvements attained over time. A critical aspect of their work involves the assessment and therapeutic management of psychosocial determinants of obesity, as well as comorbid mental health conditions—such as eating disorders, mood fluctuations, anxiety syndromes, or depressive episodes. Additionally, the psychologist focuses on cultivating the patient’s deeper self-awareness regarding personal behavioral patterns, emotional responses, and defense mechanisms, thereby facilitating the adoption of enduring, health-promoting lifestyle modifications.